Bostwick Laboratories: New Personalized Genetic Test- ProstaVysionTM- Helps Prostate Cancer Patients Make Best Treatment Decisions  
5/12/2011 11:24:51 AM

Treatment of prostate cancer is often confusing for patients, but ProstaVysion™ – the first personalized genetic panel for prostate cancer – optimizes that choice by defining the aggressiveness of the cancer. Exclusively from Bostwick Laboratories® and available immediately, ProstaVysionTM examines the genetic status of that patient’s prostate cancer.